RAVICTI

Approval Id: c717adc014429fc0
Drug Approval Canada Name: RAVICTI
Product Name: RAVICTI
Status: Marketed
Status Date: 2016-11-03
Original Market Date: 2016-11-03
Din: 02453304
Drug Class: Human
Dosage Form: Liquid
Route Of Administration: Oral
Schedule: Prescription
Atc Original: A16AX09 GLYCEROL PHENYLBUTYRATE
Atc Name: a 16 ax 09
Aig Number: 0157990001
Company Name: HORIZON THERAPEUTICS IRELAND DAC
Company Address: Pottery Road, Dun Laoghaire Co. Dublin, Dublin, Ireland, A96F2A8
Company Detail Path: /organization/horizon-therapeutics-ireland-dac

GLYCEROL PHENYLBUTYRATE

1.1 G / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c717adc014429fc0

Type

Standard